Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Ability of An Innovative Screening Method To Identify Proteomic Changes In Cancer Patients- Protocol

NCT01883388 is registered in ClinicalTrials.gov with Fore Biotherapeutics as lead sponsor.

NCT NCT01883388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01883388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Ability of An Innovative Screening Method To Identify Proteomic Changes In Cancer Patients- Protocol
Lead sponsor
Fore Biotherapeutics
Phase
Observational
Overall status
Completed
Start date
June 30, 2013
Completion date
Not reported
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer